Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein.
Identifieur interne : 000C61 ( Ncbi/Merge ); précédent : 000C60; suivant : 000C62Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein.
Auteurs : Vinit M. Supekar [Italie] ; Chiara Bruckmann ; Paolo Ingallinella ; Elisabetta Bianchi ; Antonello Pessi ; Andrea CarfíSource :
- Proceedings of the National Academy of Sciences of the United States of America [ 0027-8424 ] ; 2004.
Descripteurs français
- KwdFr :
- Antigènes viraux (), Conformation des protéines, Cristallographie aux rayons X, Dimérisation, Données de séquences moléculaires, Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires (), Glycoprotéines membranaires (métabolisme), Membrane cellulaire (métabolisme), Modèles moléculaires, Mutation, Paramyxoviridae (métabolisme), Peptides (), Protéines de fusion virale (), Protéines de l'enveloppe virale (), Protéines de l'enveloppe virale (métabolisme), Similitude de séquences d'acides aminés, Structure secondaire des protéines, Structure tertiaire des protéines, Séquence conservée, Séquence d'acides aminés.
- MESH :
- métabolisme : Glycoprotéines membranaires, Membrane cellulaire, Paramyxoviridae, Protéines de l'enveloppe virale.
- Antigènes viraux, Conformation des protéines, Cristallographie aux rayons X, Dimérisation, Données de séquences moléculaires, Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires, Modèles moléculaires, Mutation, Peptides, Protéines de fusion virale, Protéines de l'enveloppe virale, Similitude de séquences d'acides aminés, Structure secondaire des protéines, Structure tertiaire des protéines, Séquence conservée, Séquence d'acides aminés.
English descriptors
- KwdEn :
- Amino Acid Sequence, Antigens, Viral (chemistry), Cell Membrane (metabolism), Conserved Sequence, Crystallography, X-Ray, Dimerization, Membrane Glycoproteins (chemistry), Membrane Glycoproteins (metabolism), Models, Molecular, Molecular Sequence Data, Mutation, Paramyxoviridae (metabolism), Peptides (chemistry), Protein Conformation, Protein Structure, Secondary, Protein Structure, Tertiary, Sequence Homology, Amino Acid, Spike Glycoprotein, Coronavirus, Viral Envelope Proteins (chemistry), Viral Envelope Proteins (metabolism), Viral Fusion Proteins (chemistry).
- MESH :
- chemical , chemistry : Antigens, Viral, Membrane Glycoproteins, Peptides, Viral Envelope Proteins, Viral Fusion Proteins.
- metabolism : Cell Membrane, Membrane Glycoproteins, Paramyxoviridae, Viral Envelope Proteins.
- Amino Acid Sequence, Conserved Sequence, Crystallography, X-Ray, Dimerization, Models, Molecular, Molecular Sequence Data, Mutation, Protein Conformation, Protein Structure, Secondary, Protein Structure, Tertiary, Sequence Homology, Amino Acid, Spike Glycoprotein, Coronavirus.
Abstract
A coronavirus (CoV) has recently been identified as the causative agent of the severe acute respiratory syndrome (SARS) in humans. CoVs enter target cells through fusion of viral and cellular membranes mediated by the viral envelope glycoprotein S. We have determined by x-ray crystallography the structure of a proteolytically stable core fragment from the heptad repeat (HR) regions HR1 and HR2 of the SARS-CoV S protein. We have also determined the structure of an HR1-HR2 S core fragment, containing a shorter HR1 peptide and a C-terminally longer HR2 peptide that extends up to the transmembrane region. In these structures, three HR1 helices form a parallel coiled-coil trimer, whereas three HR2 peptides pack in an oblique and antiparallel fashion into the coiled-coil hydrophobic grooves, adopting mixed extended and alpha-helical conformations as in postfusion paramyxoviruses F proteins structures. Our structure positions a previously proposed internal fusion peptide adjacent to the N-terminus of HR1. Peptides from the HR2 region of SARS-CoV S have been shown to inhibit viral entry and infection in vitro. The structures presented here can thus open the path to the design of small-molecule inhibitors of viral entry and candidate vaccine antigens against this virus.
DOI: 10.1073/pnas.0406128102
PubMed: 15604146
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002A05
- to stream PubMed, to step Curation: 002A05
- to stream PubMed, to step Checkpoint: 002A12
Links to Exploration step
pubmed:15604146Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein.</title><author><name sortKey="Supekar, Vinit M" sort="Supekar, Vinit M" uniqKey="Supekar V" first="Vinit M" last="Supekar">Vinit M. Supekar</name><affiliation wicri:level="1"><nlm:affiliation>Istituto di Ricerche di Biologia Molecolare P. Angeletti, Via Pontina Km 30,600, 00040 Pomezia (Rome), Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Ricerche di Biologia Molecolare P. Angeletti, Via Pontina Km 30,600, 00040 Pomezia (Rome)</wicri:regionArea><wicri:noRegion>00040 Pomezia (Rome)</wicri:noRegion></affiliation></author><author><name sortKey="Bruckmann, Chiara" sort="Bruckmann, Chiara" uniqKey="Bruckmann C" first="Chiara" last="Bruckmann">Chiara Bruckmann</name></author><author><name sortKey="Ingallinella, Paolo" sort="Ingallinella, Paolo" uniqKey="Ingallinella P" first="Paolo" last="Ingallinella">Paolo Ingallinella</name></author><author><name sortKey="Bianchi, Elisabetta" sort="Bianchi, Elisabetta" uniqKey="Bianchi E" first="Elisabetta" last="Bianchi">Elisabetta Bianchi</name></author><author><name sortKey="Pessi, Antonello" sort="Pessi, Antonello" uniqKey="Pessi A" first="Antonello" last="Pessi">Antonello Pessi</name></author><author><name sortKey="Carfi, Andrea" sort="Carfi, Andrea" uniqKey="Carfi A" first="Andrea" last="Carfí">Andrea Carfí</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15604146</idno><idno type="pmid">15604146</idno><idno type="doi">10.1073/pnas.0406128102</idno><idno type="wicri:Area/PubMed/Corpus">002A05</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002A05</idno><idno type="wicri:Area/PubMed/Curation">002A05</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002A05</idno><idno type="wicri:Area/PubMed/Checkpoint">002A12</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A12</idno><idno type="wicri:Area/Ncbi/Merge">000C61</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein.</title><author><name sortKey="Supekar, Vinit M" sort="Supekar, Vinit M" uniqKey="Supekar V" first="Vinit M" last="Supekar">Vinit M. Supekar</name><affiliation wicri:level="1"><nlm:affiliation>Istituto di Ricerche di Biologia Molecolare P. Angeletti, Via Pontina Km 30,600, 00040 Pomezia (Rome), Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Ricerche di Biologia Molecolare P. Angeletti, Via Pontina Km 30,600, 00040 Pomezia (Rome)</wicri:regionArea><wicri:noRegion>00040 Pomezia (Rome)</wicri:noRegion></affiliation></author><author><name sortKey="Bruckmann, Chiara" sort="Bruckmann, Chiara" uniqKey="Bruckmann C" first="Chiara" last="Bruckmann">Chiara Bruckmann</name></author><author><name sortKey="Ingallinella, Paolo" sort="Ingallinella, Paolo" uniqKey="Ingallinella P" first="Paolo" last="Ingallinella">Paolo Ingallinella</name></author><author><name sortKey="Bianchi, Elisabetta" sort="Bianchi, Elisabetta" uniqKey="Bianchi E" first="Elisabetta" last="Bianchi">Elisabetta Bianchi</name></author><author><name sortKey="Pessi, Antonello" sort="Pessi, Antonello" uniqKey="Pessi A" first="Antonello" last="Pessi">Antonello Pessi</name></author><author><name sortKey="Carfi, Andrea" sort="Carfi, Andrea" uniqKey="Carfi A" first="Andrea" last="Carfí">Andrea Carfí</name></author></analytic><series><title level="j">Proceedings of the National Academy of Sciences of the United States of America</title><idno type="ISSN">0027-8424</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term><term>Antigens, Viral (chemistry)</term><term>Cell Membrane (metabolism)</term><term>Conserved Sequence</term><term>Crystallography, X-Ray</term><term>Dimerization</term><term>Membrane Glycoproteins (chemistry)</term><term>Membrane Glycoproteins (metabolism)</term><term>Models, Molecular</term><term>Molecular Sequence Data</term><term>Mutation</term><term>Paramyxoviridae (metabolism)</term><term>Peptides (chemistry)</term><term>Protein Conformation</term><term>Protein Structure, Secondary</term><term>Protein Structure, Tertiary</term><term>Sequence Homology, Amino Acid</term><term>Spike Glycoprotein, Coronavirus</term><term>Viral Envelope Proteins (chemistry)</term><term>Viral Envelope Proteins (metabolism)</term><term>Viral Fusion Proteins (chemistry)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antigènes viraux ()</term><term>Conformation des protéines</term><term>Cristallographie aux rayons X</term><term>Dimérisation</term><term>Données de séquences moléculaires</term><term>Glycoprotéine de spicule des coronavirus</term><term>Glycoprotéines membranaires ()</term><term>Glycoprotéines membranaires (métabolisme)</term><term>Membrane cellulaire (métabolisme)</term><term>Modèles moléculaires</term><term>Mutation</term><term>Paramyxoviridae (métabolisme)</term><term>Peptides ()</term><term>Protéines de fusion virale ()</term><term>Protéines de l'enveloppe virale ()</term><term>Protéines de l'enveloppe virale (métabolisme)</term><term>Similitude de séquences d'acides aminés</term><term>Structure secondaire des protéines</term><term>Structure tertiaire des protéines</term><term>Séquence conservée</term><term>Séquence d'acides aminés</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antigens, Viral</term><term>Membrane Glycoproteins</term><term>Peptides</term><term>Viral Envelope Proteins</term><term>Viral Fusion Proteins</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Cell Membrane</term><term>Membrane Glycoproteins</term><term>Paramyxoviridae</term><term>Viral Envelope Proteins</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Glycoprotéines membranaires</term><term>Membrane cellulaire</term><term>Paramyxoviridae</term><term>Protéines de l'enveloppe virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term><term>Conserved Sequence</term><term>Crystallography, X-Ray</term><term>Dimerization</term><term>Models, Molecular</term><term>Molecular Sequence Data</term><term>Mutation</term><term>Protein Conformation</term><term>Protein Structure, Secondary</term><term>Protein Structure, Tertiary</term><term>Sequence Homology, Amino Acid</term><term>Spike Glycoprotein, Coronavirus</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Antigènes viraux</term><term>Conformation des protéines</term><term>Cristallographie aux rayons X</term><term>Dimérisation</term><term>Données de séquences moléculaires</term><term>Glycoprotéine de spicule des coronavirus</term><term>Glycoprotéines membranaires</term><term>Modèles moléculaires</term><term>Mutation</term><term>Peptides</term><term>Protéines de fusion virale</term><term>Protéines de l'enveloppe virale</term><term>Similitude de séquences d'acides aminés</term><term>Structure secondaire des protéines</term><term>Structure tertiaire des protéines</term><term>Séquence conservée</term><term>Séquence d'acides aminés</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A coronavirus (CoV) has recently been identified as the causative agent of the severe acute respiratory syndrome (SARS) in humans. CoVs enter target cells through fusion of viral and cellular membranes mediated by the viral envelope glycoprotein S. We have determined by x-ray crystallography the structure of a proteolytically stable core fragment from the heptad repeat (HR) regions HR1 and HR2 of the SARS-CoV S protein. We have also determined the structure of an HR1-HR2 S core fragment, containing a shorter HR1 peptide and a C-terminally longer HR2 peptide that extends up to the transmembrane region. In these structures, three HR1 helices form a parallel coiled-coil trimer, whereas three HR2 peptides pack in an oblique and antiparallel fashion into the coiled-coil hydrophobic grooves, adopting mixed extended and alpha-helical conformations as in postfusion paramyxoviruses F proteins structures. Our structure positions a previously proposed internal fusion peptide adjacent to the N-terminus of HR1. Peptides from the HR2 region of SARS-CoV S have been shown to inhibit viral entry and infection in vitro. The structures presented here can thus open the path to the design of small-molecule inhibitors of viral entry and candidate vaccine antigens against this virus.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15604146</PMID><DateCompleted><Year>2005</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>101</Volume><Issue>52</Issue><PubDate><Year>2004</Year><Month>Dec</Month><Day>28</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein.</ArticleTitle><Pagination><MedlinePgn>17958-63</MedlinePgn></Pagination><Abstract><AbstractText>A coronavirus (CoV) has recently been identified as the causative agent of the severe acute respiratory syndrome (SARS) in humans. CoVs enter target cells through fusion of viral and cellular membranes mediated by the viral envelope glycoprotein S. We have determined by x-ray crystallography the structure of a proteolytically stable core fragment from the heptad repeat (HR) regions HR1 and HR2 of the SARS-CoV S protein. We have also determined the structure of an HR1-HR2 S core fragment, containing a shorter HR1 peptide and a C-terminally longer HR2 peptide that extends up to the transmembrane region. In these structures, three HR1 helices form a parallel coiled-coil trimer, whereas three HR2 peptides pack in an oblique and antiparallel fashion into the coiled-coil hydrophobic grooves, adopting mixed extended and alpha-helical conformations as in postfusion paramyxoviruses F proteins structures. Our structure positions a previously proposed internal fusion peptide adjacent to the N-terminus of HR1. Peptides from the HR2 region of SARS-CoV S have been shown to inhibit viral entry and infection in vitro. The structures presented here can thus open the path to the design of small-molecule inhibitors of viral entry and candidate vaccine antigens against this virus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Supekar</LastName><ForeName>Vinit M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Istituto di Ricerche di Biologia Molecolare P. Angeletti, Via Pontina Km 30,600, 00040 Pomezia (Rome), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruckmann</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Ingallinella</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Bianchi</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Pessi</LastName><ForeName>Antonello</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Carfí</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>2BEQ</AccessionNumber><AccessionNumber>2BEZ</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578553">MHV surface projection glycoprotein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014760">Viral Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017124" MajorTopicYN="N">Conserved Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019281" MajorTopicYN="N">Dimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010252" MajorTopicYN="N">Paramyxoviridae</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017433" MajorTopicYN="N">Protein Structure, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014760" MajorTopicYN="N">Viral Fusion Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>12</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>3</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>12</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15604146</ArticleId><ArticleId IdType="pii">0406128102</ArticleId><ArticleId IdType="doi">10.1073/pnas.0406128102</ArticleId><ArticleId IdType="pmc">PMC539766</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2662-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10077567</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 1999 Mar;3(3):309-19</Citation><ArticleIdList><ArticleId IdType="pubmed">10198633</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Struct Biol. 1999 May;6(5):458-63</Citation><ArticleIdList><ArticleId IdType="pubmed">10331874</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Biochem. 2000;69:531-69</Citation><ArticleIdList><ArticleId IdType="pubmed">10966468</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2003 May 30;278(22):20278-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12654905</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Mol Cell Biol. 2003 Apr;4(4):309-19</Citation><ArticleIdList><ArticleId IdType="pubmed">12671653</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 May 15;423(6937):240</Citation><ArticleIdList><ArticleId IdType="pubmed">12748632</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2003 May;2(5):345-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12755128</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2003 Aug;77(16):8801-11</Citation><ArticleIdList><ArticleId IdType="pubmed">12885899</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 2003 Oct 27;163(2):363-74</Citation><ArticleIdList><ArticleId IdType="pubmed">14581458</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Struct Biol. 2003 Dec;10(12):1048-53</Citation><ArticleIdList><ArticleId IdType="pubmed">14595397</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2004 Jan 30;279(5):3197-201</Citation><ArticleIdList><ArticleId IdType="pubmed">14670965</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2431-41</Citation><ArticleIdList><ArticleId IdType="pubmed">14681510</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4240-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15010527</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2004 Mar 20;363(9413):938-47</Citation><ArticleIdList><ArticleId IdType="pubmed">15043961</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2004 Jun 4;279(23):24141-51</Citation><ArticleIdList><ArticleId IdType="pubmed">15060075</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2004 Jul 16;279(29):30514-22</Citation><ArticleIdList><ArticleId IdType="pubmed">15123674</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Jun;78(11):5642-50</Citation><ArticleIdList><ArticleId IdType="pubmed">15140961</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15150417</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8709-14</Citation><ArticleIdList><ArticleId IdType="pubmed">15161975</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3</Citation><ArticleIdList><ArticleId IdType="pubmed">15299374</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2004 Nov 19;279(47):49414-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15345712</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2025413</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1990 Dec;71 ( Pt 12):3075-80</Citation><ArticleIdList><ArticleId IdType="pubmed">2177097</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Enzymol. 1997;276:307-26</Citation><ArticleIdList><ArticleId IdType="pubmed">27754618</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 1987 Aug 20;196(4):963-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3681988</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1994 Sep 1;371(6492):37-43</Citation><ArticleIdList><ArticleId IdType="pubmed">8072525</ArticleId></ArticleIdList></Reference><Reference><Citation>Proteins. 1996 Oct;26(2):134-45</Citation><ArticleIdList><ArticleId IdType="pubmed">8916221</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1997 Apr 18;89(2):263-73</Citation><ArticleIdList><ArticleId IdType="pubmed">9108481</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1997 May 22;387(6631):426-30</Citation><ArticleIdList><ArticleId IdType="pubmed">9163431</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21</Citation><ArticleIdList><ArticleId IdType="pubmed">9757107</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 1998 Nov;2(5):605-16</Citation><ArticleIdList><ArticleId IdType="pubmed">9844633</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Italie</li></country></list><tree><noCountry><name sortKey="Bianchi, Elisabetta" sort="Bianchi, Elisabetta" uniqKey="Bianchi E" first="Elisabetta" last="Bianchi">Elisabetta Bianchi</name><name sortKey="Bruckmann, Chiara" sort="Bruckmann, Chiara" uniqKey="Bruckmann C" first="Chiara" last="Bruckmann">Chiara Bruckmann</name><name sortKey="Carfi, Andrea" sort="Carfi, Andrea" uniqKey="Carfi A" first="Andrea" last="Carfí">Andrea Carfí</name><name sortKey="Ingallinella, Paolo" sort="Ingallinella, Paolo" uniqKey="Ingallinella P" first="Paolo" last="Ingallinella">Paolo Ingallinella</name><name sortKey="Pessi, Antonello" sort="Pessi, Antonello" uniqKey="Pessi A" first="Antonello" last="Pessi">Antonello Pessi</name></noCountry><country name="Italie"><noRegion><name sortKey="Supekar, Vinit M" sort="Supekar, Vinit M" uniqKey="Supekar V" first="Vinit M" last="Supekar">Vinit M. Supekar</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C61 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000C61 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:15604146
|texte= Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:15604146" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |